Sando-K® is an effervescent tablet, containing 0.6g potassium chloride, and 0.4g potassium bicarbonate and is indicated for the prevention and treatment of hypokalaemia.
Hypokalaemia can be caused by potassium depleting drugs such as frusemide, thiazide diuretics, corticosteroids, carbenoxolone and cardiac glycosides. It can also be commonly caused by severe diarrhoea, vomiting or fistulas; Acid-base disturbances such as alkalosis, renal tubular acidosis and states in which there is aldosterone excess such as Cushing syndrome; Decreased intake of potassium due to malnutrition, alcoholism, and elderly patients with deficient diets. Since Sando-K® contains chloride, it can also be used to treat hypochloraemic alkalosis.
Each Sando-K® tablet delivers 12mmol of K+ and the usual dose is 2-4 tablets daily in most patients. Severe potassium depletion usually warrants IV replacement, but in less severe cases 8-16 tablets of Sando-K® can be used daily instead.
Each box of Sando-K® contains five tubes of twenty tablets.
